Your browser doesn't support javascript.
loading
Renal involvement in sarcoidosis: histological patterns and prognosis, an Italian survey.
Rastelli, Francesco; Baragetti, Ivano; Buzzi, Laura; Ferrario, Francesca; Benozzi, Luisa; Di Nardo, Francesco; Devoti, Elisabetta; Cancarini, Giovanni; Mezzina, Nicoletta; Napodano, Pietro; Gallieni, Maurizio; Santoro, Domenico; Buemi, Michele; Pecchini, Paola; Malberti, Fabio; Colombo, Valeriana; Colussi, Giacomo; Sabadini, Ettore; Remuzzi, Giuseppe; Argentiero, Lucia; Gesualdo, Loreto; Gatti, Guido; Trevisani, Francesco; Slaviero, Giorgio; Spotti, Donatella; Baraldi, Olga; La Manna, Gaetano; Pignone, Eugenia; Saltarelli, Marco; Heidempergher, Marco; Tedesco, Michela; Genderini, Augusto; Ferro, Michela; Rollino, Cristiana; Roccatello, Dario; Guzzo, Gabriella; Clari, Roberta; Barbara Piccoli, Giorgina; Comotti, Cristina; Brunori, Giuliano; Cameli, Paolo; Bargagli, Elena; Rottoli, Paola; Dugo, Mauro; Cristina Maresca, Maria; Bertoli, Massimo; Giozzet, Morena; Brugnano, Rachele; Giovanni Nunzi, Emidio; D'Amico, Marco.
  • Rastelli F; Nephrology SS. Trinità Hospital, Borgomanero, Italy.
  • Baragetti I; Nephrology Bassini Hospital, Cinisello Balsamo, Italy.
  • Buzzi L; Nephrology Bassini Hospital, Cinisello Balsamo, Italy.
  • Ferrario F; Nephrology Bassini Hospital, Cinisello Balsamo, Italy.
  • Benozzi L; Nephrology Bassini Hospital, Cinisello Balsamo, Italy.
  • Di Nardo F; Nephrology SS. Trinità Hospital, Borgomanero, Italy.
  • Devoti E; Prevention Department, SS. Trinità Hospital, Borgomanero, Italy.
  • Cancarini G; Nephrology Spedali Civili, Brescia, Italy.
  • Mezzina N; Nephrology Spedali Civili, Brescia, Italy.
  • Napodano P; Nephrology S.Carlo Hospital, Milano, Italy.
  • Gallieni M; Nephrology S.Carlo Hospital, Milano, Italy.
  • Santoro D; Nephrology Policlinico G.Martino, Messina, Italy.
  • Buemi M; Nephrology Policlinico G.Martino, Messina, Italy.
  • Pecchini P; Nephrology Policlinico G.Martino, Messina, Italy.
  • Malberti F; Nephrology Istituti Ospitalieri, Cremona, Italy.
  • Colombo V; Nephrology Istituti Ospitalieri, Cremona, Italy.
  • Colussi G; Nephrology Niguarda Hospital, Milano, Italy.
  • Sabadini E; Nephrology Niguarda Hospital, Milano, Italy.
  • Remuzzi G; Nephrology Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Argentiero L; Nephrology Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Gesualdo L; Clinical Research Centre for Rare Diseases, Mario Negri Institute for Pharmacological Research, Pediatric Nephrology Department Bergamo, Italy.
  • Gatti G; Nephrology Policlinico di Bari, Italy.
  • Trevisani F; Nephrology Policlinico di Bari, Italy.
  • Slaviero G; Nephrology S.Raffaele Hospital, Milano, Italy.
  • Spotti D; Nephrology S.Raffaele Hospital, Milano, Italy.
  • Baraldi O; Nephrology S.Raffaele Hospital, Milano, Italy.
  • La Manna G; Nephrology S.Raffaele Hospital, Milano, Italy.
  • Pignone E; Nephrology Policlino Sant'Orsola-Malpighi, Bologna, Italy.
  • Saltarelli M; Nephrology Policlino Sant'Orsola-Malpighi, Bologna, Italy.
  • Heidempergher M; Nephrology Ospedale degli Infermi, Rivoli, Italy.
  • Tedesco M; Nephrology Ospedale degli Infermi, Rivoli, Italy.
  • Genderini A; Nephrology Sacco Hospital, Milano, Italy.
  • Ferro M; Nephrology Sacco Hospital, Milano, Italy.
  • Rollino C; Nephrology Sacco Hospital, Milano, Italy.
  • Roccatello D; Nephrology S.Giovanni Bosco Hospital, Torino, Italy.
  • Guzzo G; Nephrology S.Giovanni Bosco Hospital, Torino, Italy.
  • Clari R; Nephrology S.Giovanni Bosco Hospital, Torino, Italy.
  • Barbara Piccoli G; Nephrology S.Luigi Hospital, Orbassano, Italy.
  • Comotti C; Nephrology S.Luigi Hospital, Orbassano, Italy.
  • Brunori G; Nephrology S.Luigi Hospital, Orbassano, Italy.
  • Cameli P; Nephrologie Centre Hospitalier du Mans, Le Mans, France.
  • Bargagli E; Nephrology S.Chiara Hospital, Trento, Italy.
  • Rottoli P; Nephrology S.Chiara Hospital, Trento, Italy.
  • Dugo M; Pneumology S.Maria alle Scotte Hospital, Siena, Italy.
  • Cristina Maresca M; Pneumology S.Maria alle Scotte Hospital, Siena, Italy.
  • Bertoli M; Pneumology S.Maria alle Scotte Hospital, Siena, Italy.
  • Giozzet M; Nephrology S.Maria dei Battuti Hospital, Treviso, Italy.
  • Brugnano R; Nephrology S.Maria dei Battuti Hospital, Treviso, Italy.
  • Giovanni Nunzi E; Nephrology S.Maria del Prato Hospital, Feltre, Italy.
  • D'Amico M; Nephrology S.Maria del Prato Hospital, Feltre, Italy.
Sarcoidosis Vasc Diffuse Lung Dis ; 38(3): e2021017, 2021.
Article en En | MEDLINE | ID: mdl-34744417
ABSTRACT

BACKGROUND:

Granulomatous interstitial nephritis in sarcoidosis (sGIN) is generally clinically silent, but in <1% causes acute kidney injury (AKI).

METHODS:

This Italian multicentric retrospective study included 39 sarcoidosis-patients with renal involvement at renal biopsy 31 sGIN-AKI, 5 with other patterns (No-sGIN-AKI), 3 with nephrotic proteinuria. We investigate the predictive value of clinical features, laboratory, radiological parameters and histological patterns regarding steroid response. Primary endpoint incident chronic kidney disease (CKD) beyond the 1°follow-up (FU) year; secondary endpoint response at 1°line steroid therapy; combined endpoint the association of initial steroid response and outcome at the end of FU.

RESULTS:

Complete recovery in all 5 No-sGIN-AKI-patients, only in 45% (13/29) sGIN-AKI-patients (p=0.046) (one lost in follow-up, for another not available renal function after steroids). Nobody had not response. Primary endpoint of 22 sGIN-AKI

subjects:

65% (13/20) starting with normal renal function developed CKD (2/22 had basal CKD; median FU 77 months, 15-300). Combined endpoint 29% (6/21) had complete recovery and final normal renal function (one with renal relapse), 48% (10/21) had partial recovery and final CKD (3 with renal relapse, of whom one with basal CKD) (p=0.024). Acute onset and hypercalcaemia were associated to milder AKI and better recovery than subacute onset and patients without hypercalcaemia, women had better endpoints than men. Giant cells, severe interstitial infiltrate and interstitial fibrosis seemed negative predictors in terms of endpoints.

CONCLUSIONS:

sGIN-AKI-patients with no complete recovery at 1°line steroid should be treated with other immunosuppressive to avoid CKD, in particular if males with subacute onset and III stage-not hypercalcaemic AKI.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Año: 2021 Tipo del documento: Article